ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,620, issued on April 21, was assigned to LG CHEM Ltd. (Seoul, South Korea).
"Anti-LILRB1 antibody and uses thereof" was invented by Yoon Aa Choi (Daejeon, South Korea), Han Byul Kim (Daejeon, South Korea), Shinyoung Kang (Daejeon, South Korea), Jung A Kim (Daejeon, South Korea), Heehang Kim (Daejeon, South Korea), Minsoon Kim (Daejeon, South Korea) and Junhaeng Cho (Daejeon, South Korea).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to an anti-LILRB1 antibody having increased specificity for LILRB1, and to uses thereof. Specifically, an anti-LILRB1 antibody or an antigen-binding fragment thereof, and uses thereof in tr...